中国医药导刊
中國醫藥導刊
중국의약도간
CHINESE JOURNAL OF MEDICAL GUIDE
2013年
3期
468
,共1页
噻托溴铵%普米克令舒%老年%慢性阻塞性肺疾病
噻託溴銨%普米剋令舒%老年%慢性阻塞性肺疾病
새탁추안%보미극령서%노년%만성조새성폐질병
Tiotropium Bromide%Budesonide%Older%Chronic Obstructive Pulmonary Disease
目的:探讨噻托溴铵和普米克令舒治疗老年慢性阻塞性肺疾病(COPD)临床疗效情况.方法:分析我院收治的COPD患者临床资料,对照组(单独应用普米克令舒治疗组)40例和观察组(噻托溴铵联合普米克令舒治疗组)40例.结果:观察组肺功能和生活质量均明显优于对照组,P<0.05,差异均有统计学意义.结论:噻托溴铵和普米克令舒联合治疗COPD临床症状改善明显.
目的:探討噻託溴銨和普米剋令舒治療老年慢性阻塞性肺疾病(COPD)臨床療效情況.方法:分析我院收治的COPD患者臨床資料,對照組(單獨應用普米剋令舒治療組)40例和觀察組(噻託溴銨聯閤普米剋令舒治療組)40例.結果:觀察組肺功能和生活質量均明顯優于對照組,P<0.05,差異均有統計學意義.結論:噻託溴銨和普米剋令舒聯閤治療COPD臨床癥狀改善明顯.
목적:탐토새탁추안화보미극령서치료노년만성조새성폐질병(COPD)림상료효정황.방법:분석아원수치적COPD환자림상자료,대조조(단독응용보미극령서치료조)40례화관찰조(새탁추안연합보미극령서치료조)40례.결과:관찰조폐공능화생활질량균명현우우대조조,P<0.05,차이균유통계학의의.결론:새탁추안화보미극령서연합치료COPD림상증상개선명현.
@@@@Objective: To approach clinical curative effect of curing older chronic obstructive pulmonary disease by tiotropium bromide and budesonide. Method:To analyze clinical data of of curing older chronic obstructive pulmonary disease by tiotropium bromide and budesonide,which was to be divided into control group(Separate application of Pulmicort Respules to treat group)40 cases and detection group(Tiotropium bromide combined with Pulmicort Respules to treat group)40 cases. Result:The pulmonary function and quality of life of detection group were better than control group,P<0.05,the difference were statistical significance. Conclusion:The clinical symptoms of curing older chronic obstructive pulmonary disease by tiotropium bromide and budesonide was obviously and effect of good.